Company news
iBio, Inc. news in 2020
iBio, Inc.'s news releases, calls and decks from 2020, newest first.
iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer
December 27, 2020
iBio Announces Closing of its Public Offering of Common Stock
December 9, 2020
iBio Announces Pricing of $35 Million Public Offering of Common Stock
December 7, 2020
iBio Announces Proposed Public Offering of Common Stock
December 6, 2020
iBio Selected to Produce ATB Therapeutics’ Bioengineered Antibody-Toxin Fusion Proteins
November 30, 2020
iBio Announces Issuance of U.S. Patent Covering Endostatin Peptides for Treating Fibrosis
November 23, 2020
iBio Reports Fiscal First Quarter 2021 Financial Results and Provides Corporate Update
November 15, 2020
iBio Announces Appointment of Randy J. Maddux as Chief Operating Officer
November 2, 2020
iBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors
October 14, 2020
Accomplished Financial Executive, Gary Sender, Joins iBio’s Board of Directors
October 14, 2020
iBio Announces Appointment of Dr. Linda Armstrong to Board of Directors
October 13, 2020
iBio Announces Financial Results for Fiscal Year Ended June 30, 2020
October 12, 2020
iBio Regains Compliance with NYSE American Continued Listing Standards
October 4, 2020
iBio to Advance COVID-19 LicKM-Subunit Vaccine Candidate, IBIO-201
September 8, 2020
iBio and Planet Biotechnology Enter into Exclusive Worldwide License Agreement for the Development of a COVID-19 Therapeutic
August 27, 2020
iBio Provides Update on IBIO-201 COVID-19 Vaccine Program
August 9, 2020
iBio Announces Second COVID-19 Vaccine Program
June 3, 2020
iBio Estimates ~500 Million Dose Capacity for COVID-19 Vaccine from its FastPharming Facility™
April 26, 2020
iBio Expands COVID-19 Vaccine Collaboration to Include the Infectious Disease Research Institute
April 8, 2020
iBio Announces Advancement of COVID-19 Vaccine Program
March 25, 2020
iBio Joins the Alliance for Biosecurity
March 19, 2020
iBio Announces Development of Proprietary COVID-19 Vaccine Candidates
March 17, 2020
iBio Announces Leadership Succession, Appoints Thomas F. Isett Co-Chairman & CEO
March 11, 2020
iBio, Inc. Announces Withdrawal of Proxy Statement Proposal to Amend Its Certificate of Incorporation to Authorize a Possible Reverse Stock Split
March 1, 2020
iBio, Inc. Announces Postponement of Annual Meeting
February 5, 2020
iBio, Inc. Announces NYSE American Acceptance of Plan of Compliance
January 15, 2020
iBio Initiates New Litigation Against Fraunhofer
January 5, 2020